
Auteur R. VANDREY
|
Documents disponibles écrits par cet auteur (5)

R. VANDREY ; J. C. RABER ; M. E. RABER ; B. DOUGLASS ; C. MILLER ; M. O. BONN-MILLER | 2015
Dans Journal of the American Medical Association (Vol.313, n°24, June 23/30, 2015) Article : PériodiqueRegulation and quality assurance for edible product cannabinoid content and labeling are generally lacking. We investigated the label accuracy of edible cannabis products.
R. VANDREY ; A. J. BUDNEY ; J. L. KAMON ; C. STANGER | 2005
Dans Drug and Alcohol Dependence (Vol.78, n°2, May 2005) Article : PériodiqueA valid cannabis withdrawal syndrome has been demonstrated in controlled studies with adult marijuana abusers, yet few published reports have examined cannabis withdrawal among adolescents. Adolescents presenting for outpatient substance abuse t[...]
A. J. BUDNEY ; J. R. HUGHES ; B. A. MOORE ; R. VANDREY | 2004
Dans American Journal of Psychiatry (Vol.161, n°11, November 2004) Article : PériodiqueThe authors review the literature examining the validity and significance of cannabis withdrawal syndrome. Findings from animal laboratory research are briefly reviewed, and human laboratory and clinical studies are surveyed in more detail. Conv[...]
R. VANDREY ; K. E. DUNN ; J. A. FRY ; E. R. GIRLING | 2012
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : PériodiqueBACKGROUND: Synthetic cannabinoids are a rapidly emerging class of abused drugs. Synthetic cannabinoids are typically sold as "herbal blends" or "incense," commonly referred to as Spice products. No controlled human experiments have been conduct[...]
V. LORENZETTI ; C. HINDOCHA ; K. PETRILLI ; P. GRIFFITHS ; J. BROWN ; A. CASTILLO-CARNIGLIA ; J. P. CAULKINS ; A. ENGLUND ; M. A. ElSOHLY ; S. H. GAGE ; T. GROSHKOVA ; A. GUAL ; D. HAMMOND ; W. LAWN ; H. LOPEZ-PELAYO ; J. MANTHEY ; C. MOKRYSZ ; R. L. PACULA ; M. VAN LAAR ; R. VANDREY ; E. WADSWORTH ; A. WINSTOCK ; W. HALL ; H. V. CURRAN ; T. P. FREEMAN | 2022
Dans Addiction (Vol.117, n°6, June 2022) Article : PériodiqueBACKGROUND: The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence on the psychosocial, neurocognitive, clinical and public health consequences of cannabis use. METH[...]